| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol binding | 1.02e-04 | 16 | 19 | 2 | GO:0019992 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 2.34e-04 | 24 | 19 | 2 | GO:0017075 | |
| GeneOntologyMolecularFunction | syntaxin binding | 3.06e-03 | 87 | 19 | 2 | GO:0019905 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 8.04e-07 | 2 | 19 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 4.82e-06 | 4 | 19 | 2 | GO:0061789 | |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 3.60e-05 | 10 | 19 | 2 | GO:0099525 | |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 5.28e-05 | 12 | 19 | 2 | GO:0099011 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle priming | 7.27e-05 | 14 | 19 | 2 | GO:0010807 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 8.38e-05 | 15 | 19 | 2 | GO:1990504 | |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 1.08e-04 | 17 | 19 | 2 | GO:0016081 | |
| GeneOntologyBiologicalProcess | regulation of short-term neuronal synaptic plasticity | 1.84e-04 | 22 | 19 | 2 | GO:0048172 | |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 2.38e-04 | 25 | 19 | 2 | GO:0048791 | |
| GeneOntologyBiologicalProcess | dense core granule localization | 3.00e-04 | 28 | 19 | 2 | GO:0032253 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 3.68e-04 | 31 | 19 | 2 | GO:0016082 | |
| GeneOntologyBiologicalProcess | innervation | 4.43e-04 | 34 | 19 | 2 | GO:0060384 | |
| GeneOntologyBiologicalProcess | secretory granule localization | 4.43e-04 | 34 | 19 | 2 | GO:0032252 | |
| GeneOntologyBiologicalProcess | vesicle docking involved in exocytosis | 7.43e-04 | 44 | 19 | 2 | GO:0006904 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.96e-04 | 23 | 19 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | MLL1 complex | 3.82e-04 | 32 | 19 | 2 | GO:0071339 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 4.06e-04 | 33 | 19 | 2 | GO:0044665 | |
| GeneOntologyCellularComponent | calyx of Held | 4.84e-04 | 36 | 19 | 2 | GO:0044305 | |
| GeneOntologyCellularComponent | cell cortex region | 7.57e-04 | 45 | 19 | 2 | GO:0099738 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.09e-03 | 75 | 19 | 2 | GO:0035097 | |
| Domain | Unc-13 | 2.94e-06 | 3 | 19 | 2 | IPR027080 | |
| Domain | Munc13_dom-2 | 9.79e-06 | 5 | 19 | 2 | IPR014772 | |
| Domain | Membr_traf_MHD | 9.79e-06 | 5 | 19 | 2 | PF10540 | |
| Domain | DUF1041 | 9.79e-06 | 5 | 19 | 2 | SM01145 | |
| Domain | MHD2 | 9.79e-06 | 5 | 19 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 9.79e-06 | 5 | 19 | 2 | IPR019558 | |
| Domain | DUF1041 | 2.05e-05 | 7 | 19 | 2 | PF06292 | |
| Domain | Munc13_1 | 2.05e-05 | 7 | 19 | 2 | IPR014770 | |
| Domain | CAPS_dom | 2.05e-05 | 7 | 19 | 2 | IPR010439 | |
| Domain | MHD1 | 2.05e-05 | 7 | 19 | 2 | PS51258 | |
| Domain | ZINC_FINGER_C2H2_2 | 8.69e-04 | 775 | 19 | 5 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 8.79e-04 | 777 | 19 | 5 | PS00028 | |
| Domain | Znf_C2H2-like | 9.80e-04 | 796 | 19 | 5 | IPR015880 | |
| Domain | Znf_C2H2 | 1.03e-03 | 805 | 19 | 5 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.05e-03 | 808 | 19 | 5 | SM00355 | |
| Domain | C1_1 | 1.51e-03 | 57 | 19 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 1.90e-03 | 64 | 19 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.90e-03 | 64 | 19 | 2 | PS50081 | |
| Domain | C1 | 1.96e-03 | 65 | 19 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 2.02e-03 | 66 | 19 | 2 | IPR002219 | |
| Domain | zf-C2H2 | 4.67e-03 | 693 | 19 | 4 | PF00096 | |
| Domain | Peptidase_S1A | 5.80e-03 | 113 | 19 | 2 | IPR001314 | |
| Domain | TRYPSIN_DOM | 6.00e-03 | 115 | 19 | 2 | PS50240 | |
| Domain | Tryp_SPc | 6.21e-03 | 117 | 19 | 2 | SM00020 | |
| Domain | Trypsin | 6.62e-03 | 121 | 19 | 2 | PF00089 | |
| Domain | Trypsin_dom | 6.62e-03 | 121 | 19 | 2 | IPR001254 | |
| Domain | Peptidase_S1_PA | 6.84e-03 | 123 | 19 | 2 | IPR009003 | |
| Domain | C2 | 7.72e-03 | 131 | 19 | 2 | PF00168 | |
| Domain | C2 | 8.42e-03 | 137 | 19 | 2 | SM00239 | |
| Domain | C2 | 9.02e-03 | 142 | 19 | 2 | PS50004 | |
| Domain | - | 9.76e-03 | 148 | 19 | 2 | 2.60.40.150 | |
| Domain | - | 1.00e-02 | 449 | 19 | 3 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.07e-02 | 459 | 19 | 3 | IPR013083 | |
| Domain | C2_dom | 1.19e-02 | 164 | 19 | 2 | IPR000008 | |
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 2.83e-07 | 2 | 19 | 2 | 31851910 | |
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 2.83e-07 | 2 | 19 | 2 | 28426965 | |
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 2.83e-07 | 2 | 19 | 2 | 28489077 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 35613050 | ||
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 2.83e-07 | 2 | 19 | 2 | 11832228 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 23770256 | ||
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 2.83e-07 | 2 | 19 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 2.83e-07 | 2 | 19 | 2 | 22066784 | |
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 2.83e-07 | 2 | 19 | 2 | 30816091 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 2.83e-07 | 2 | 19 | 2 | 23229896 | |
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 2.83e-07 | 2 | 19 | 2 | 32187536 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 12070347 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 11792326 | ||
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 2.83e-07 | 2 | 19 | 2 | 28772123 | |
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 2.83e-07 | 2 | 19 | 2 | 19558619 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 12871971 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 18701688 | ||
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 2.83e-07 | 2 | 19 | 2 | 17267576 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 17561838 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 22814762 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 23070049 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 33105896 | ||
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 8.48e-07 | 3 | 19 | 2 | 37343100 | |
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 17639022 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 22966208 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 23658173 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 15988013 | ||
| Pubmed | Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo. | 1.70e-06 | 4 | 19 | 2 | 10488064 | |
| Pubmed | Fbxo45, a novel ubiquitin ligase, regulates synaptic activity. | 1.70e-06 | 4 | 19 | 2 | 19996097 | |
| Pubmed | Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing. | 1.70e-06 | 4 | 19 | 2 | 15123597 | |
| Pubmed | ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. | 1.70e-06 | 4 | 19 | 2 | 28264913 | |
| Pubmed | 2.82e-06 | 5 | 19 | 2 | 22248876 | ||
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 2.82e-06 | 5 | 19 | 2 | 34706221 | |
| Pubmed | 2.82e-06 | 5 | 19 | 2 | 32755572 | ||
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 2.82e-06 | 5 | 19 | 2 | 33139401 | |
| Pubmed | Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis. | 2.82e-06 | 5 | 19 | 2 | 26575293 | |
| Pubmed | Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of synaptic vesicles. | 4.24e-06 | 6 | 19 | 2 | 28635948 | |
| Pubmed | 5.93e-06 | 7 | 19 | 2 | 15893389 | ||
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 5.93e-06 | 7 | 19 | 2 | 36398873 | |
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 7.90e-06 | 8 | 19 | 2 | 25609709 | |
| Pubmed | SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. | 1.27e-05 | 10 | 19 | 2 | 21040848 | |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 1.55e-05 | 11 | 19 | 2 | 34767769 | |
| Pubmed | The morphological and molecular nature of synaptic vesicle priming at presynaptic active zones. | 1.55e-05 | 11 | 19 | 2 | 25374362 | |
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 9.12e-05 | 26 | 19 | 2 | 17124501 | |
| Pubmed | 1.30e-04 | 31 | 19 | 2 | 15217342 | ||
| Pubmed | 1.30e-04 | 31 | 19 | 2 | 15960975 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q21 | 2.45e-03 | 178 | 19 | 2 | chr7q21 | |
| GeneFamily | UNC13 homologs | 3.34e-06 | 4 | 14 | 2 | 836 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.79e-03 | 718 | 14 | 4 | 28 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-05 | 110 | 19 | 3 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.74e-05 | 168 | 19 | 3 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.91e-05 | 170 | 19 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 173 | 19 | 3 | 4f849d236ee358ad30ac977745ac43c8e9778e94 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 173 | 19 | 3 | 39c3b8313354c4c60764597507a2505dcfa4e8c7 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 5.26e-05 | 174 | 19 | 3 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.54e-05 | 177 | 19 | 3 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-05 | 179 | 19 | 3 | 40c65e8623547aeb80f9cd2366e29072467ce069 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.92e-05 | 181 | 19 | 3 | 2b9b460239d67fd480cee60820cdb306109d3567 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.92e-05 | 181 | 19 | 3 | 2a1aa4a0ec7bc367857beaff543135e4345c835b | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.42e-05 | 186 | 19 | 3 | 9579180db2a0bf3f043b4d169f9a08cdc45b459a | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.16e-05 | 193 | 19 | 3 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.84e-05 | 199 | 19 | 3 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | COVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class | 7.84e-05 | 199 | 19 | 3 | 0230103c37ae3aff58240739b89f2c36b1e39a69 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Rgs14_(CA2_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.68e-04 | 67 | 19 | 2 | 771fc7c4917b5dc5ebf1b7be304d62902f0b75cc | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Rgs14_(CA2_Principal_cells)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.68e-04 | 67 | 19 | 2 | f56d8787ab2170997d28a2f66d83b4c18362b97d | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gabra5)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.24e-04 | 72 | 19 | 2 | 480653f8bd0ef118cb8d541103692e3ec8a1b58d | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.36e-04 | 73 | 19 | 2 | 51bcbb57ee6c45cad88cb3e2cedab2cf3503b2a5 | |
| ToppCell | droplet-Fat-Scat-21m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-04 | 97 | 19 | 2 | 6fff45d4c4bbd81a67e1ad12b131cfe6a5ab37e6 | |
| ToppCell | droplet-Fat-Scat-21m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-04 | 97 | 19 | 2 | 440d45ecfc9b66cb61d734118601e745892d51e3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-04 | 98 | 19 | 2 | 95162072f3afc95e46f29db3d79ebd930bc09726 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.33e-04 | 107 | 19 | 2 | 5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.33e-04 | 107 | 19 | 2 | 410b37beffaf637a2a64c9d0ce7baf81f4bc667c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.51e-04 | 108 | 19 | 2 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-hematologic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.29e-03 | 126 | 19 | 2 | f2ec5aa6c649ae1ff99519f6897cf207dc292edf | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-hematologic-erythrocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.29e-03 | 126 | 19 | 2 | cd02f3d4a3fadd24f3a298639b392f0354d227d2 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.29e-03 | 126 | 19 | 2 | 61a7e400cbc81691b21cd3c37376c1d19fec2270 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-5|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.52e-03 | 137 | 19 | 2 | a7c76201b8901b2ef7ebbb4dfe0cec0dc4534ef5 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.52e-03 | 137 | 19 | 2 | 291b4eeaf21ec951695621161dbc2de3e82ca993 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 139 | 19 | 2 | 82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25 | |
| ToppCell | facs-Liver-Hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 139 | 19 | 2 | fc4b39ac9a10cf0acacfebbc4295edf324d930d5 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 139 | 19 | 2 | fc9ac09c2106e88104a52575832d71d17765eec8 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 139 | 19 | 2 | 4ddfbc36a0560fb70594627178bff652ab1ea3e9 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.59e-03 | 140 | 19 | 2 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 1.59e-03 | 140 | 19 | 2 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.61e-03 | 141 | 19 | 2 | 73b3e967357cba7585d97ec9e9d48d3e94ebe31e | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-03 | 143 | 19 | 2 | ce045ec7c311a1797ae562bec114f9e90604d063 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.68e-03 | 144 | 19 | 2 | 4f46a22dba047d35076e7768e834b0cbcecc8417 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-03 | 145 | 19 | 2 | 07acbf086cffce0628accf078d31bf190f803988 | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 1.72e-03 | 146 | 19 | 2 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-03 | 149 | 19 | 2 | 797b5f267e86fbe1d7af99df514d8074446603c6 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.82e-03 | 150 | 19 | 2 | 6a13e4c4b9c9e54a5016573a37132465ec1c8f99 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-03 | 152 | 19 | 2 | 0fda8980b10ce16179dea92301db74d728f41794 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-03 | 154 | 19 | 2 | f92d83c5f8b532fe5624f1cd352632f543d96ea9 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 156 | 19 | 2 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 156 | 19 | 2 | 1c2920f4356789a9c11d5ea1eaafb18a50b19ed7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 156 | 19 | 2 | a45fbe02cd03bd4a097f21368bc1179779ba0db8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 156 | 19 | 2 | 0695ac0f02d059ecf813d61d3c9d4c76d1d85834 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 157 | 19 | 2 | eb64a4e89843895d16015c7d51805f164ed7ea5b | |
| ToppCell | Monocytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.01e-03 | 158 | 19 | 2 | c3096b3a914a1a15ebe3664613e94b951f8555fc | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 2.01e-03 | 158 | 19 | 2 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 158 | 19 | 2 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 158 | 19 | 2 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 158 | 19 | 2 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 158 | 19 | 2 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 158 | 19 | 2 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-03 | 159 | 19 | 2 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-03 | 159 | 19 | 2 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-03 | 159 | 19 | 2 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 2.09e-03 | 161 | 19 | 2 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.09e-03 | 161 | 19 | 2 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 2.09e-03 | 161 | 19 | 2 | 15ba7e69699558353cfeecdcf1dbc2e147379ed6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-03 | 162 | 19 | 2 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-03 | 162 | 19 | 2 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-03 | 163 | 19 | 2 | f6847f47a8856c0d4136c1af317432d45eccfde9 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-03 | 163 | 19 | 2 | a1fbefe53523a9879a4d4b493071059798b5f917 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-03 | 163 | 19 | 2 | 454a5e87e2f9f66e38cc5aa1b433c47b54c9be42 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-03 | 163 | 19 | 2 | be6cc44df9a2b10dce1a353717c279c3558f8fec | |
| ToppCell | 5'-Airway_Nasal_SMG|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-03 | 163 | 19 | 2 | d8450bf9c6d2ec5dd1472952c9e65f82f995337a | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-03 | 163 | 19 | 2 | d9bd9d90cfa4e85d5ea51f8f3ee14a700571f508 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-03 | 164 | 19 | 2 | f1423f4434af4af9c60c8a5b0b0abec4a7df9401 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-03 | 164 | 19 | 2 | cdb8cd2d6b369189ea77e4946738e2816d502e03 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-03 | 164 | 19 | 2 | 5dbfcdd450f652b16d97da53b528d4584b0eabcf | |
| ToppCell | Int-URO-Myeloid-cDC1|Int-URO / Disease, Lineage and Cell Type | 2.17e-03 | 164 | 19 | 2 | f4628a7ff0dc765a5337ab499b3d61fc25573a16 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-03 | 165 | 19 | 2 | cca3ba9d7d30404e3e683b8cfd500c348a4974b9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-03 | 165 | 19 | 2 | 9de841c1c95967c562720feba930246debc626fd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.19e-03 | 165 | 19 | 2 | fee7f2f8d0e25c0d067adc73f8913721bd709a3e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-03 | 165 | 19 | 2 | cdc94a640ec01c6892521bcd6f0ee0a66ff23866 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-03 | 165 | 19 | 2 | a612a7d3a5415ecacc3df8fbff0ce498f982aad0 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.22e-03 | 166 | 19 | 2 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.22e-03 | 166 | 19 | 2 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.25e-03 | 167 | 19 | 2 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-03 | 167 | 19 | 2 | a21a2b301d0a3d7a41e605f7a3c37548962a331d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-03 | 167 | 19 | 2 | 0e746483773bde6582874a33591ab2a578d724eb | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.25e-03 | 167 | 19 | 2 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-03 | 167 | 19 | 2 | 7f3224af9b30082b927a822b91f96e0c88151b4e | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-03 | 167 | 19 | 2 | 6c2dade24a88af04b2c90a7e4f8dd7ccea9e94d1 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-03 | 167 | 19 | 2 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-03 | 167 | 19 | 2 | 99db8871c62336bd215efb65e969783d2b6003b0 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.27e-03 | 168 | 19 | 2 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-03 | 168 | 19 | 2 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-03 | 168 | 19 | 2 | d8f485f8459532a2cb0bef899e6569142cf75685 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.30e-03 | 169 | 19 | 2 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.30e-03 | 169 | 19 | 2 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-03 | 169 | 19 | 2 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 2.30e-03 | 169 | 19 | 2 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.30e-03 | 169 | 19 | 2 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.30e-03 | 169 | 19 | 2 | 9c4e83fe8225d16173a103bf5a57b17d623be923 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-03 | 170 | 19 | 2 | 021c3e45955d18e241f7d98acdf22076fee4fc43 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.33e-03 | 170 | 19 | 2 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| Disease | graft-versus-host disease (is_implicated_in) | 5.31e-05 | 17 | 19 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | cardioembolic stroke | 1.70e-04 | 170 | 19 | 3 | EFO_1001976 | |
| Disease | Acute Cerebrovascular Accidents | 5.51e-04 | 54 | 19 | 2 | C0751956 | |
| Disease | Antithrombotic agent use measurement | 5.72e-04 | 55 | 19 | 2 | EFO_0009925 | |
| Disease | calcium measurement | 6.11e-04 | 628 | 19 | 4 | EFO_0004838 | |
| Disease | Cerebrovascular accident | 7.26e-04 | 62 | 19 | 2 | C0038454 | |
| Disease | Nonsyndromic Deafness | 1.23e-03 | 81 | 19 | 2 | C3711374 | |
| Disease | complement factor D measurement | 1.62e-03 | 93 | 19 | 2 | EFO_0020283 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELQVCVKDYCFARED | 1616 | Q9UPW8 | |
| REIRYLDEVLEANCC | 51 | Q9Y2D5 | |
| ERDVETICRAILVYC | 1476 | Q9HCK8 | |
| CERRFLSEVDYLVCV | 196 | P16442 | |
| EEAIRPYVSRCAVCE | 1556 | P53420 | |
| RVCFVQCFSEADRDI | 131 | Q2TB18 | |
| VCVEDCVVLVDYTIR | 261 | P23469 | |
| CCEEVRDYVEERSGE | 36 | P63211 | |
| VRYEVCDIPQCSEVE | 196 | P14210 | |
| IVRVEYRCPECDKVF | 286 | Q96T92 | |
| LDEVTQRCVYLEDCV | 1451 | Q6ZRI0 | |
| DRYDFEVVRCICEVQ | 646 | Q9BVI0 | |
| IDYRAIVSRRCCEEV | 171 | Q5MJ70 | |
| KECYEEICVYEEARE | 56 | P22891 | |
| QLCEICEVSEENYIR | 21 | P20061 | |
| ERVQAEKRQYVCTEC | 41 | Q6AZW8 | |
| QICVKDYCFAREDRV | 1511 | O14795 | |
| EQRYCAVCREELRQV | 61 | Q86UK7 | |
| DVFRFLVEERIQCCQ | 471 | Q92995 | |
| CEVCDYETNVARNLR | 806 | Q15911 |